trending Market Intelligence /marketintelligence/en/news-insights/trending/iEUiaD6eRzbdn-oA1_JNiA2 content esgSubNav
In This List

Applied DNA Sciences fiscal Q2 loss widens 83.9% YOY

Blog

Global smart TV forecast return to growth in 2022, sustained through 2026

Case Study

Broad Environmental Data Guides an Insurer’s Journey to Net Zero

Blog

Broadcast deal market recap, Q2'22

Blog

Japan M&A By the Numbers: Q1 2022


Applied DNA Sciences fiscal Q2 loss widens 83.9% YOY

Applied DNA Sciences Inc. said its normalized net income for the fiscal second quarter ended March 31 amounted to a loss of 9 cents per share, compared with the S&P Capital IQ consensus estimate of a loss of 10 cents per share.

The per-share loss increased 32.6% year over year from 7 cents.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was a loss of $2.2 million, compared with a loss of $1.2 million in the prior-year period.

Total revenue fell 62.3% year over year to $573,320 from $1.5 million, and total operating expenses increased 18.3% year over year to $4.0 million from $3.4 million.

Reported net income came to a loss of $3.5 million, or a loss of 14 cents per share, compared to a loss of $1.9 million, or a loss of 11 cents per share, in the year-earlier period.